Procore Technologies Inc SEC Filings

A Form 144 notice discloses a planned insider sale of common stock. The Kevin J O'Connor Revocable Trust dtd 06/13/19 has filed to sell up to 61,536 common shares through Goldman Sachs & Co. LLC on the NYSE, with an aggregate market value of $3,874,306.56 and an approximate sale date of 01/21/2026. Common shares outstanding were 155,469,860 as of the filing, which is a baseline ownership figure.

The shares to be sold were originally acquired from the issuer in private transactions in 2004 and 2006. The trust has also been an active seller in recent months, with multiple sales of common shares during November and December 2025, including blocks such as 5,769 shares on 11/13/2025 for $439,480.11 and 28,504 shares on 11/12/2025 for $2,230,523.51.

Procore Technologies, Inc. chairman Craig F. Courtemanche Jr. reported exercising two stock option awards into common stock. On January 13, 2026, he exercised options to acquire 69,941 shares at $2.42 per share and 22,833 shares at $12.22 per share.

Following these transactions, his direct holding of Procore common stock increased to 864,897 shares. He also reports indirect ownership through several family trusts holding 2,692,461, 1,155,480 and 527,349 shares, plus 23,736 shares held by his spouse.

Procore Technologies filed a Form 4 showing a small planned stock sale by its Chief Financial Officer and Treasurer. On 01/02/2026, the reporting officer sold 814 shares of Procore common stock at a price of $72.99 per share. After this transaction, the officer beneficially owns 178,237 shares of common stock.

The filing notes that the shares were sold pursuant to a Rule 10b5-1 trading plan dated November 15, 2024, indicating the transaction was executed under a pre-arranged plan rather than a discretionary trade.

Procore Technologies insider plans additional stock sale under Rule 144. An affiliate of the company, identified as Howard Fu, filed a notice to sell 814 shares of Procore common stock through Morgan Stanley Smith Barney LLC, with an aggregate market value of $59,413.86 on the NYSE. The shares to be sold were acquired as restricted stock from the issuer on 11/20/2025.

Over the prior three months, the same seller reported three sales of Procore common stock: 796 shares on 12/22/2025 for $59,238.32, 797 shares on 11/21/2025 for $55,271.95, and 814 shares on 10/21/2025 for $58,884.76. The notice also includes the standard representation that the seller does not know of any undisclosed material adverse information about Procore’s current or prospective operations.

Procore Technologies, Inc. reported that its Chief Financial Officer and Treasurer filed an insider trading report for a planned stock sale. On 12/22/2025, the executive sold 796 shares of Procore common stock at a price of $74.42 per share under a pre-arranged Rule 10b5-1 trading plan dated November 15, 2024.

After this transaction, the executive beneficially owns 179,051 shares of Procore common stock in direct ownership. The filing notes that the transaction was carried out pursuant to the preset plan intended to satisfy the affirmative defense conditions of Rule 10b5-1(c), which is designed to allow insiders to trade according to a pre-established schedule.

Procore Technologies, Inc. reported an insider equity transaction by its SVP, Corporate Controller. On 12/22/2025, the officer exercised a stock option (coded "M") to acquire 7,250 shares of common stock at an exercise price of $12.22 per share.

Following this transaction, the officer beneficially owns 68,556 shares of Procore common stock directly and continues to hold 20,170 stock options. The option originally began vesting with one‑quarter of the shares vesting on June 4, 2019, and the remainder vesting in equal monthly installments thereafter, subject to continued service, with an expiration date of June 17, 2028.

Procore Technologies insider trading notice: A holder of Procore Technologies (symbol PCOR) common stock has filed a notice to sell 796 shares of common stock through Morgan Stanley Smith Barney LLC on the NYSE, with an aggregate market value of $59,238.32. These shares were acquired as restricted stock from the issuer on 11/20/2025, and Procore had 155,469,860 common shares outstanding. The same seller previously sold 797 common shares on 11/21/2025 for gross proceeds of $55,271.95 and 814 common shares on 10/21/2025 for gross proceeds of $58,884.76. By signing the notice, the seller represents that they do not know of any undisclosed material adverse information about the company’s operations.

Procore Technologies, Inc. reported an insider stock sale by a director who also serves as Chairman of the Board. On 12/15/2025, the reporting person indirectly sold 64,707 shares of common stock at a weighted average price of $72.62 and a further 10,293 shares at a weighted average price of $73.21, through an entity identified as the Courtemanche 2021 Irrevocable Trust.

Following these transactions, that trust beneficially owned 1,155,480 shares of Procore common stock. The filing also lists additional shares held directly, as well as through other family trusts and the reporting person’s spouse, indicating that the reporting person continues to have a significant indirect and direct equity interest in the company.

Procore Technologies director and 10% owner William J.G. Griffith reported selling 207,474 shares of Procore common stock on 12/15/2025 at a weighted average price of $72.298 per share. Following this sale, he beneficially owned 3,244,546 shares directly. He also reported indirect ownership through ICONIQ Strategic Partners investment funds, including 2,634,478 shares held by ICONIQ Strategic Partners III, L.P., and 2,814,976 shares held by ICONIQ Strategic Partners III-B, L.P., along with additional positions in related ICONIQ III, IV, V and VI entities.